#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11362	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2073	540.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1684	1684	T	612	T,C,A	588,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11362	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2073	540.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	641	C	621	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21440	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3513	603.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1640	1640	A	670	A	655	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21440	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3513	603.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2274	2274	C	661	C	638	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21440	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3513	603.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2348	2348	A	686	A	667	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21440	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3513	603.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2900	2900	C	661	C,T,A	640,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1600	folP	855	855	100.0	folP.l15.c4.ctg.1	1553	101.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1068	1070	AGC	163;165;163	A;G;C	159;158;154	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4626	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3305	138.2	1	SNP	p	S91F	1	.	.	271	273	TTC	498	500	TTC	156;155;155	T;T;C	155;154;152	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4626	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3305	138.2	1	SNP	p	D95G	1	.	.	283	285	GGC	510	512	GGC	151;149;152	G;G;C	147;146;148	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4626	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3305	138.2	1	SNP	p	G95N	0	.	.	283	285	GGC	510	512	GGC	151;149;152	G;G;C	147;146;148	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1312	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1390	92.9	1	SNP	p	G45D	0	.	.	133	135	GGC	543	545	GGC	159;158;158	G;G;C	157;155;154	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	724	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	948	75.6	0	.	n	.	0	A197.	DEL	197	197	A	592	592	A	157	A	150	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3940	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2930	133.3	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1437	1439	GTC	146;144;143	G;T;C	143;141;141	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3940	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2930	133.3	1	SNP	p	D86N	0	.	.	256	258	GAC	543	545	GAC	171;171;173	G;A;C	168;165;171	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3940	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2930	133.3	1	SNP	p	R87I	0	.	.	259	261	CGT	546	548	CGT	172;173;176	C,A;G;T	168,1;170;166	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3940	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2930	133.3	1	SNP	p	S87R	1	.	.	259	261	CGT	546	548	CGT	172;173;176	C,A;G;T	168,1;170;166	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3940	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2930	133.3	1	SNP	p	R87W	0	.	.	259	261	CGT	546	548	CGT	172;173;176	C,A;G;T	168,1;170;166	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3940	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2930	133.3	1	SNP	p	S88P	0	.	.	262	264	TCC	549	551	TCC	176;174;175	T;C;C	172;168;170	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3434	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2484	135.8	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1236	1238	TGC	162;155;156	T,C;G,A;C	153,1;150,1;152	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3434	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2484	135.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1446	1448	GGC	160;158;155	G;G;C	154;151;148	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3084	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2389	127.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1250	1252	GCA	181;180;178	G;C;A,C	176;173;174,1	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3084	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2389	127.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1253	1255	ATC	181;182;183	A;T;C,T,G	176;177;174,1,1	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3084	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2389	127.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1265	1267	GTG	188;186;185	G,C;T,A;G	180,1;175,1;177	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3084	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2389	127.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1265	1267	GTG	188;186;185	G,C;T,A;G	180,1;175,1;177	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3084	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2389	127.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1769	1771	ACC	141;142;142	A;C;C	136;140;139	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3084	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2389	127.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1823	1825	GCG	104;103;102	G;C,G;G	98;87,1;96	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3084	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2389	127.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1823	1825	GCG	104;103;102	G;C,G;G	98;87,1;96	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3084	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2389	127.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1946	1948	GGC	120;115;115	G;G;C	117;112;111	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3084	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2389	127.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1955	1957	GGC	109;108;108	G,C;G;C,T	103,1;104;105,1	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3084	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2389	127.4	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1973	1975	TCG	89;90;91	T,G,C;C;G	61,14,1;74;72	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4484	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3121	142.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1644	1646	CCG	166;166;165	C;C;G,A	153;160;160,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2060	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1680	120.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	494	494	C	137	C	129	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2082	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1549	132.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	470	472	GAA	158;160;162	G;A;A	151;155;155	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2082	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1549	132.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	758	760	GAT	177;179;178	G;A;T	171;175;174	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2082	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1549	132.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	881	883	TCA	167;166;169	T;C;A	164;162;166	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2082	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1549	132.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1010	1012	GTC	151;150;150	G;T;C,T,A	145;142;144,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2082	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1549	132.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1022	1024	TCT	152;150;149	T;C;T	141;143;144	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2082	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1549	132.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1340	1342	GCA	176;177;179	G,T;C,A;A	172,1;173,1;175	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2082	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1549	132.8	1	SNP	p	G120K	1	.	.	358	360	AAG	716	718	AAG	170;167;169	A;A;G	166;165;165	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2082	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1549	132.8	1	SNP	p	D121N	0	.	.	361	363	GAC	719	721	GAC	172;173;174	G;A;C	167;167;170	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2082	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1549	132.8	1	SNP	p	A121D	1	.	.	361	363	GAC	719	721	GAC	172;173;174	G;A;C	167;167;170	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7880	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	4912	158.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1985	1987	AAT	163;163;166	A;A;T	158;159;160	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	938	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1166	79.7	1	SNP	p	V57M	1	.	.	169	171	ATG	555	557	ATG	191;192;189	A;T;G	188;189;186	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
